Cargando…
Inhibition of glycogen synthase kinase 3β prevents NSAID-induced acute kidney injury
Clinical use of non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac (DCLF) is limited by multiple adverse effects, including renal toxicity leading to acute kidney injury. In mice with DCLF-induced nephrotoxicity TDZD-8, a selective glycogen synthase kinase (GSK)3β inhibitor, improved acu...
Autores principales: | Bao, Hao, Ge, Yan, Zhuang, Shougang, Dworkin, Lance D, Liu, Zhihong, Gong, Rujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305839/ https://www.ncbi.nlm.nih.gov/pubmed/22258319 http://dx.doi.org/10.1038/ki.2011.443 |
Ejemplares similares
-
Fine-tuning of NFκB by Glycogen Synthase Kinase 3β directs the fate of glomerular podocytes upon injury
por: Bao, Hui, et al.
Publicado: (2015) -
The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury
por: Li, Changbin, et al.
Publicado: (2015) -
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020) -
Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease
por: Tao, Shixin, et al.
Publicado: (2015) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)